|
Report Date : |
04.09.2012 |
IDENTIFICATION DETAILS
|
Name : |
UNITED LABORATORIES, INC. |
|
|
|
|
|
|
Registered Office : |
66 United Street, Brgy. Highway Hills, Mandaluyong City 1550 |
|
|
|
|
|
|
Country : |
Philippines |
|
|
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
|
|
Date of Incorporation : |
10.08.1953; 03.12.1997 (extension) |
|
|
|
|
|
|
Com. Reg. No.: |
8205 |
|
|
|
|
|
|
Legal Form : |
Corporation |
|
|
|
|
|
|
Line of Business : |
Manufacturer,
exporter, and distributor of pharmaceutical products. |
|
|
|
|
|
|
No. of Employees : |
About 2,300 |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
-- |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Philippines |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
PHILIPPINES - ECONOMIC OVERVIEW
Philippine GDP grew 7.6% in 2010, spurred by consumer demand, a rebound in exports and investments, and election-related spending, before cooling to 3.7% in 2011. The economy weathered the 2008-09 global recession better than its regional peers due to minimal exposure to troubled international securities, lower dependence on exports, relatively resilient domestic consumption, large remittances from four- to five-million overseas Filipino workers, and a growing business process outsourcing industry. Economic growth in the Philippines averaged 4.5% during the MACAPAGAL-ARROYO administration (January 2001 - June 2010). Despite this growth, however, poverty worsened during her presidency. The AQUINO administration is working to reduce the government deficit from 3.9% of GDP, when it took office, to 2% of GDP by 2013. The government has had little difficulty issuing debt, both locally and internationally, to finance the deficits. The AQUINO Administration reduced public debt to below 50% of GDP and obtained several ratings upgrades on sovereign debt so that the Philippines is now close to investment grade. However, the lack of government spending, especially on infrastructure, was one of several factors which slowed GDP growth in the second half of 2011, leading the government to announce a stimulus effort and increased public spending on infrastructure in 2012. AQUINO's first budget emphasized education, health, conditional cash transfers for the poor, and other social spending programs, relying mostly on the private sector to finance important infrastructure projects. Weak tax collection, exacerbated by new tax breaks and incentives, has limited the government's ability to address major challenges. The AQUINO administration has vowed to focus on improving tax collection efficiency, rather than imposing new taxes, as a part of its good governance platform. The economy still faces several long-term challenges, including reliance on energy imports and foreign demand for overseas Filipino workers.
Source
: CIA
|
Company Name: |
UNITED
LABORATORIES, INC. |
|
Trading Name: |
UNILAB |
|
Supplied Name: |
United
Laboratories Inc |
|
Trading Address: |
66 United
Street, Brgy. Highway Hills, Mandaluyong City 1550, Philippines |
|
Supplied
Address: |
66 United St.
Mandaluyong City Philippines |
|
Telephone
Number: |
+63 (02)
858-1000; 631-8501; 631-8056; 631-6036; 637-8873 |
|
Fax Number: |
+63 (02)
631-6036; 637-9131; 631-3580; 858-1635 |
Note:
Subject’s complete address is as above.
|
Credit Opinion: |
Business
connections are permissible. |
|
Company Name: |
UNITED
LABORATORIES, INC. |
|
Registered
Number: |
8205 |
|
Legal Form: |
Corporation |
|
Date
Incorporated: |
|
|
Authorized
Capital Stock: |
PHP 8,000,000,000.00 |
|
Subscribed
Capital Stock: |
PHP 5,125,000,000.00 |
|
Paid-up Capital: |
PHP 5,125,000,000.00 |
|
Listed at Stock
Exchange: |
No |
|
Staff: |
About 2,300
office personnel, production, and field representatives (per available report
dated March 26, 2012) |
Note:
Amounts in Philippine Peso unless otherwise
specified
CORPORATION
Verification with the local registry revealed the following correct
registration details as of (August 31, 2012).
Company Background
|
Regulatory Agency |
Date Registered |
Registration No. |
Term |
|
Securities and Exchange Commission |
|
8205 |
50 years |
|
Securities and Exchange Commission |
|
8205 |
50 years |
As of 12/22/2011
|
Type |
Amount |
Par Value |
|
Authorized Capital (Organizer’s Stock) |
2,000,000,000.00 |
25.00 |
|
Authorized Capital (Common Stock) |
8,000,000,000.00 |
100.00 |
|
Subscribed and Paid Up Capital (Common Stock) |
5,125,000,000.00 |
100.00 |
|
Subscribed and Paid Up Capital (Organizer’s Stock) |
563,557,800.00 |
25.00 |
Capital structure per latest available General Information Sheet.
Increase in authorized capital stock from 200,000,000 to 450,000,000 was
approved by the Securities and Exchange Commission on June 13, 1980; to
1,500,000,000, on May 2, 1986; to 2,500,000,000 on September 21, 1990; to
5,000,000,000 on November 5, 1993; to 10,000,000,000 on February 10, 1999.
Subsidiaries:
Amherst Laboratories, Inc.; Asian Antibiotics, Inc.; Biofemme, Inc.;
Excelcorp, Inc.; First Pioneer Distribution, Inc.; Innovitelle, Inc.; Medichem
Pharmaceuticals, Inc.; Pediatrica, Inc.; Phil. Health Food Mfg., Inc.; Reliance
Health Services, Inc.; Ritemed Phils., Inc.; Unilab Nutritionals, Inc.; UNAHCO,
Inc. (formerly Univet Agricultural Products, Inc.); Westmont Pharmaceuticals,
Inc.
Affiliates:
Adenphar Pharmaceuticals, Inc.; Alaxan Corp.; Allerin, Inc.; Banner
Health, Inc.; Biogesic, Inc.; Biomedis, Inc.; Chiron United, Inc.; Consumer
Products, Inc.; Data Processing Ser. Corp.; Decolgen Corp.; Diatabs Corp.; Enervon
Corp.; General Drug & Chemical Co., Inc.; Globalmed Health Solutions, Inc.;
HighPoint Holdings, Inc.; Infosource Holdings, Inc.; Kremil Corp.; Life Foods
of America, Inc.; LR Imperial, Inc.; Medway Pharmaceuticals, Inc.; Myra
Pharmaceuticals, Inc.; Neozep, Inc.; Noves Healthworks Corp.; Novexscience,
Inc.; Pharma Express Co.; Solmux, Inc.; The Krieger Confectionery Corp.;
Therapharma, Inc.; Treasure Valley Land Development Corp.; Tuseran Corporation;
ULIVaccines, Inc.; Unilab Air, Inc.; Unilab Generics, Inc.; Unilab Information
Technology, Inc.; Unilab Properties, Inc.; Unipharma, Inc.; Uniskin Corp.;
United American Pharmaceuticals, Inc.; United Brand Management, Inc.; United
Home Femina, Inc.; United Home Products, Inc.; Active Research & Mgt. Corp.;
Narra Princeton Holdings Limited; Dao Investment Mgt. Corp.; Dolmar Real Est.
Dev. Corp.; Dynavision Dev. Inv. Corp.; Northwest Marine Drive Co. Ltd.;
Rainbow Real Est. Corp.; Ultra Resources Holdings, Inc.; Castleton Land
Development Corp.; Rockland Realty Corp.; Balibago Land Corporation; Spectrum
Travel and Tours, Inc.; Sheridan LRT Holdings, Inc.; Armadillo Protective
Security Agency, Inc.; Fort Bonifacio Development Corp.; Greenfield Development
Corp.; Fortune Securities, Inc.; First Asia Business Consultants, Inc.; Gel
Pacific, Inc.; Fidelity Investment Corp.; Prudential Business Entity, Inc.;
Southern Heights Land Development Corp.; Merisant Sweetener (Philippines),
Inc.; Par Investment & Realty Corp.; Marketer’s One Network, Inc.
Stockholders (
|
Name |
Subscribed and Paid-Up |
Capital Type |
Nationality |
|
ACTIVE RESEARCH &
MGT. CORP. |
994,634,200.00 |
Subscribed and Paid Up |
Filipino |
|
NARRA PRINCETON
HOLDINGS LIMITED |
68,689,125.00 |
Subscribed and Paid Up |
Filipino |
|
DAO INVESTMENT MGT. CORP. |
624,722,525.00 |
Subscribed and Paid Up |
Filipino |
|
DOLMAR REAL EST. DEV.
CORP. |
1,275,956,175.00 |
Subscribed and Paid Up |
Filipino |
|
DYNAVISION DEV. INV.
CORP. |
1,962,233,950.00 |
Subscribed and Paid Up |
Filipino |
|
NORTHWEST MARINE DRIVE
CO. LTD. |
333,467,725.00 |
Subscribed and Paid Up |
Filipino |
|
OTHERS |
225.00 |
Subscribed and Paid Up |
Filipino |
|
RAINBOW REAL EST. CORP. |
29,229,925.00 |
Subscribed and Paid Up |
Filipino |
|
TREASURY SHARES |
257,991,975.00 |
Subscribed and Paid Up |
Filipino |
|
ULTRA RESOURCES
HOLDINGS, INC. |
140,941,400.00 |
Subscribed and Paid Up |
Filipino |
|
CAMPOS, JOSELITO D. JR. |
218,625.00 |
Subscribed and Paid Up |
Filipino |
|
HESS, JOCELYN CAMPOS |
218,625.00 |
Subscribed and Paid Up |
Filipino |
|
CAMPOS, JEFFREY D. |
218,625.00 |
Subscribed and Paid Up |
Filipino |
|
DEE, HOWARD Q. |
18,450.00 |
Subscribed and Paid Up |
Filipino |
|
TAN, MARIANO K. |
16,100.00 |
Subscribed and Paid Up |
Filipino |
|
TAN, MARIANO JOHN L.
JR. |
25.00 |
Subscribed and Paid Up |
Filipino |
|
HESS, CLINTON ANDREW |
25.00 |
Subscribed and Paid Up |
Filipino |
|
DEE, RICHARD C. |
25.00 |
Subscribed and Paid Up |
Filipino |
|
SANTOS, GIL A. |
25.00 |
Subscribed and Paid Up |
Filipino |
|
YAP, BENJAMIN W. |
25.00 |
Subscribed and Paid Up |
Filipino |
|
STA. MARIA, ANDRES B. |
25.00 |
Subscribed and Paid Up |
Filipino |
List of stockholders and their shareholdings per latest available General
Information Sheet
Management (
|
Name: |
Position: |
|
HESS, JOCELYN CAMPOS c/o 66 United Street,
Mandaluyong City |
Chairman |
|
HESS, CLINTON ANDREW c/o 66 United Street,
Mandaluyong City |
Vice Chairman /
President / Chief Executive Officer |
|
SANTOS, GIL A. c/o 66 United Street,
Mandaluyong City |
Senior Vice President /
Treasurer / Director |
|
TAN, MARIANO JOHN L.
JR. c/o 66 United Street,
Mandaluyong City |
Vice Chairman |
|
DEE, RICHARD C. c/o 66 United Street,
Mandaluyong City |
Senior Vice President /
Director |
|
STA. MARIA, ANDRES B. c/o 105 Paseo de Roxas,
Makati City |
Director |
|
YAP, BENJAMIN W. c/o 66 United Street,
Mandaluyong City |
Executive Vice
President / Chief Operating Officer / Director |
|
DIGA, JOSELITO G. c/o 66 United Street, Mandaluyong
City |
Senior Vice President /
Chief Finance Officer |
|
RAMOS-AÑONUEVO,
MARIEVIC G. c/o 105 Paseo de Roxas,
Makati City |
Corporate Secretary |
|
PANIGBATAN, BENEDICTO
P. c/o 105 Paseo de Roxas,
Makati City |
Assistant Corporate
Secretary |
|
LADRERA, LUIS R. c/o 66 United Street,
Mandaluyong City |
Assistant Corporate
Secretary |
List of officers per latest available General Information Sheet
Activities
|
|
|
Manufacturer, exporter,
and distributor of pharmaceutical products. |
|
Sales/Purchases
Information
|
|
|
Territory: |
Local |
Premises
|
|
|
Location:
Located at above address. |
|
Unit: PHP
|
|
2011.12.31 |
2010.12.31 |
|
TotalCurrentAssets |
27,086,828,010.00 |
23,291,144,529.00 |
|
Cash |
10,585,947,626.00 |
8,543,151,777.00 |
|
ShortInvest |
0.00 |
0.00 |
|
Receivable |
12,219,527,170.00 |
10,816,409,534.00 |
|
Inventory |
3,910,924,301.00 |
3,688,684,181.00 |
|
OtherCurrentAssets |
370,428,913.00 |
242,899,037.00 |
|
LongInvestTotal |
0.00 |
0.00 |
|
LongInvestSecurity |
0.00 |
0.00 |
|
LongInvestEquity |
1,766,149,285.00 |
1,794,698,567.00 |
|
LongInvestOther |
807,687,913.00 |
856,183,280.00 |
|
FixedAssetsTotal |
4,778,702,236.00 |
4,797,385,781.00 |
|
FixedAssets |
4,778,702,236.00 |
4,797,385,781.00 |
|
DepreciationTotal |
0.00 |
0.00 |
|
IntangibleAssets |
392,838,544.00 |
0.00 |
|
OtherAssets |
3,896,827,387.00 |
4,289,444,752.00 |
|
TotalAssets |
38,729,033,375.00 |
35,028,856,909.00 |
|
TotalCurrentDebt |
8,886,160,657.00 |
7,360,272,359.00 |
|
ShortLoan |
0.00 |
0.00 |
|
AccountsPayable |
8,086,729,001.00 |
6,314,178,950.00 |
|
OtherCurrentLiability |
799,431,656.00 |
1,046,093,409.00 |
|
LongLiabilityTotal |
3,042,308,406.00 |
3,052,263,757.00 |
|
LongLeases |
0.00 |
0.00 |
|
LongLoan |
0.00 |
0.00 |
|
LongLoanOther |
0.00 |
0.00 |
|
TotalLiability |
11,928,469,063.00 |
10,412,536,116.00 |
|
TotalEquity |
26,800,564,312.00 |
24,616,320,793.00 |
|
ShareCapital |
5,886,093,339.00 |
5,886,093,339.00 |
|
CapitalPaid |
0.00 |
0.00 |
|
LegalReserve |
0.00 |
0.00 |
|
SurplusReserve |
0.00 |
0.00 |
|
UndistributedProfit |
0.00 |
0.00 |
|
RetainedEarning |
20,914,470,973.00 |
18,730,227,454.00 |
|
OtherEquity |
0.00 |
0.00 |
|
TotalLiabilityAndEquity |
38,729,033,375.00 |
35,028,856,909.00 |
Unit: PHP
|
|
2011 |
2010 |
|
OperatingRevenue |
0.00 |
0.00 |
|
SalesRevenue |
29,117,474,129.00 |
27,417,626,108.00 |
|
InterestRevenue |
0.00 |
0.00 |
|
OtherRevenue |
1,044,591,926.00 |
1,027,071,379.00 |
|
TotalRevenue |
30,162,066,055.00 |
28,444,697,487.00 |
|
SalesCost |
15,707,231,489.00 |
14,559,873,895.00 |
|
GrossProfit |
13,410,242,640.00 |
12,857,752,213.00 |
|
SalesExpenses |
0.00 |
0.00 |
|
ManagementExpenses |
11,333,723,156.00 |
11,005,021,818.00 |
|
FinancialExpenses |
249,532,276.00 |
206,322,991.00 |
|
TotalExpenses |
27,290,486,921.00 |
25,771,218,704.00 |
|
OperatingProfit |
2,871,579,134.00 |
2,673,478,783.00 |
|
NonOperatingProfit |
0.00 |
0.00 |
|
ProfitBeforeTax |
2,871,579,134.00 |
2,673,478,783.00 |
|
Tax |
688,110,801.00 |
640,094,895.00 |
|
NetProfit |
2,183,468,333.00 |
2,033,383,888.00 |
|
|
2011 |
2010 |
|
OperatingNetCash |
2,723,785,456.00 |
2,142,047,743.00 |
|
InvestmentNetCash |
-385,631,392.00 |
-540,510,603.00 |
|
FinanceNetCash |
-295,358,215.00 |
-298,870,015.00 |
Citibank NA; Bank
of the Philippine Islands
Please see
attached credit exposure report under the name “UNITED LABORATORIES, INC.” as of March 31, 2012.
FORM 1: Loans and
Receivables
This section
contains credit exposure of one million and above transactions reported
quarterly by banks and other financial institutions.
For quarter ending
as of March 31, 2012
Subject: UNITED
LABORATORIES INC
|
NO |
Loan Type |
Loan Status |
Outstanding
Amount |
Market Gain/Loss |
Secured Amount |
Unsecured Amount |
|
1. |
Customers’
Liability for this Bank’s Acceptances Outstanding |
Current |
2,523,696.00 |
0.00 |
0.00 |
2,523,696.00 |
|
2. |
Customers’
Liability for this Bank’s Acceptances Outstanding |
Current |
5,263,147.00 |
0.00 |
0.00 |
5,263,147.00 |
|
3. |
31 – Accounts
Receivable |
Current |
19,002,414.00 |
0.00 |
0.00 |
19,002,414.00 |
|
4. |
Customers’
Liability for this Bank’s Acceptances Outstanding |
Current |
1,260,839.00 |
0.00 |
0.00 |
1,260,839.00 |
FORM 4: Letters of Credit/Guarantee
This section contains credit exposure records of one million and above
transactions reported quarterly by banks and other financial institutions.
For quarter ending as of March 31, 2012
Subject: UNITED
LABORATORIES INC
|
NO |
Face Value |
Amount Unavailed |
LC Type |
Notional Amount
in Peso |
|
1. |
15,264.15 |
15,264.15 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
2. |
2,294.90 |
2,294.90 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
3. |
617,104.95 |
617,104.95 |
LETTERS OF CREDIT
– Stand-by Letters of Credit |
0.00 |
|
4. |
682,392.88 |
682,392.88 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
5. |
600,000.00 |
600,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
6. |
600,000.00 |
600,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
7. |
5,000,000.00 |
5,000,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
8. |
160,000.00 |
160,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
9. |
47,615.50 |
47,615.50 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
11. |
361,180.60 |
361,180.60 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
12. |
100,000.00 |
100,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
13. |
100,000.00 |
100,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
14. |
79,796.06 |
79,796.06 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
15. |
1,400,000.00 |
1,400,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
16. |
40,710.00 |
40,710.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
17. |
36,473.60 |
36,473.60 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
18. |
3,760.45 |
3,760.45 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
19. |
84,000.00 |
84,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
20. |
1,000,000.00 |
1,000,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
21. |
3,311,233.78 |
3,311,233.78 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
22. |
36,328.50 |
36,328.50 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
23. |
300,018.76 |
300,018.76 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
24. |
35,364.40 |
35,364.40 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
25. |
100,000.00 |
100,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
26. |
317,237.65 |
317,237.65 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
27. |
432,363.60 |
432,363.60 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
28. |
10,130,021.32 |
10,130,021.32 |
GUARANTEES
ISSUED – Shipside Bonds Guarantees Issued |
0.00 |
|
29. |
74,616.65 |
74,616.65 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
30. |
640,000.00 |
640,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
31. |
76,186.88 |
76,186.88 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
32. |
181,780.46 |
181,780.46 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
33. |
9,920.85 |
9,920.85 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
34. |
400,021.29 |
400,021.29 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
35. |
253,528.26 |
253,528.26 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
36. |
7,955,565.36 |
7,955,565.36 |
GUARANTEES
ISSUED – Shipside Bonds Guarantees Issued |
0.00 |
|
37. |
5,000,000.00 |
5,000,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
38. |
30,000.00 |
30,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
39. |
35,521.40 |
35,521.40 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
40. |
24,982.84 |
24,982.84 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
41. |
12,616.00 |
12,616.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
42. |
212,990.00 |
212,990.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
43. |
387,294.24 |
387,294.24 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
44. |
102,468.50 |
102,468.50 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
45. |
66,651.95 |
66,651.95 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
46. |
1,331,969.48 |
1,331,969.48 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
47. |
55,655.24 |
55,655.24 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
48. |
90,174.80 |
90,174.80 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
49. |
99,689.40 |
99,689.40 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
50. |
100,000.00 |
100,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
51. |
1,078,059.00 |
1,078,059.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
52. |
100,000.00 |
100,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
53. |
7,768.50 |
7,768.50 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
54. |
481,556.03 |
481,556.03 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
55. |
3,291,473.64 |
3,291,473.64 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
56. |
10,000,000.00 |
10,000,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
57. |
66,744.10 |
66,744.10 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
58. |
14,700.00 |
14,700.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
59. |
35,521.40 |
35,521.40 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
60. |
175,781.46 |
175,781.46 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
61. |
45,250.00 |
45,250.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
62. |
473,256.27 |
473,256.27 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
63. |
3,240.00 |
3,240.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
64. |
132,264.46 |
132,264.46 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
65. |
254,913.59 |
254,913.59 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
66. |
200,000.00 |
200,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
67. |
399,000.00 |
399,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
68. |
276,728.91 |
276,728.91 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
69. |
608,740.00 |
608,740.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
70. |
812,104.52 |
812,104.52 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
71. |
200,000.00 |
200,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
72. |
51,770.10 |
51,770.10 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
73. |
30,000.00 |
30,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
74. |
745,567.62 |
745,567.62 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
75. |
111,563.65 |
111,563.65 |
LETTERS OF CREDIT
– Stand-by Letters of Credit |
0.00 |
|
76. |
250,099.95 |
250,099.95 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
77. |
8,965.00 |
8,965.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
78. |
10,837,457.50 |
10,837,457.50 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
79. |
46,373.00 |
46,373.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
80. |
67,657.70 |
67,657.70 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
81. |
318,613.39 |
318,613.39 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
82. |
199,942.70 |
199,942.70 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
83. |
46,645.60 |
46,645.60 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
84. |
295,675.80 |
295,675.80 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
85. |
40,710.00 |
40,710.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
86. |
18,246.09 |
18,246.09 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
87. |
50,000.00 |
50,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
88. |
4,317.56 |
4,317.56 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
89. |
59,874.71 |
59,874.71 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
90. |
107,874.71 |
107,874.71 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
91. |
500,790.00 |
500,790.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
92. |
186,411.78 |
186,411.78 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
93. |
21,351.72 |
21,351.72 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
94. |
76,541.50 |
76,541.50 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
95. |
316,051.30 |
316,051.30 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
96. |
819,252.91 |
819,252.91 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
97. |
2,000,000.00 |
2,000,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
98. |
149,993.50 |
149,993.50 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
99. |
111,561.44 |
111,561.44 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
100. |
20,221.80 |
20,221.80 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
101. |
300,000.00 |
300,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
|
102. |
16,000.00 |
16,000.00 |
LETTERS OF
CREDIT – Stand-by Letters of Credit |
0.00 |
No dealings based
on credit exposure report with one million and above dealings under the name
“UNILAB” as of March 31, 2012.
Please see
attached search results (court cases and delinquent accounts) under the name
“UNITED LABORATORIES, INC.”
ACCOUNTS REFERRED
FOR COLLECTION RESULTS
(Information in
this section refers to accounts endorsed for collection and accounts reported
as delinquent to us.)
1.
UNITED LABORATORIES
Creditor Name: NEW CENTURY TELECOMS INC (INFO
PAGE)
Endorsed Date: NA
Address: 1893 ACACIA ST EAST CAPITOL SITE CEBU
CITY
Amount: 2,130.33
Currency: PESO (PHILIPPINES)
Closed Date: NA
Status: CLOSED AND UNCOLLECTED
Reason:
Remarks:
2.
UNITED LABORATORIES INC
Creditor Name: KIMBERLY CLARK PHILIPPINES
INC
Endorsed Date:
Address: UNITED STREET MANDALUYONG CITY
Amount: 1,059.84
Currency: PESO (PHILIPPINES)
Closed Date: NA
Status: PENDING
Reason:
Remarks:
3.
UNITED LABORATORIES INC
Creditor Name: NEW CENTURY TELECOMS INC
(INFOPAGE)
Endorsed Date: NA
Address:
Amount: 2,229.08
Currency: PESO (PHILIPPINES)
Closed Date: NA
Status: CLOSED AND UNCOLLECTED
Reason:
Remarks:
4.
UNITED LABORATORIES INC (Currently updating
this record)
Creditor Name: SHANGRILA
Endorsed Date:
Address: 66 UNITED STREET MANDALUYONG
CITY
Amount: 82,094.90
Currency: PESO (PHILIPPINES)
Closed Date: NA
Status: PENDING
Reason:
Remarks:
5.
UNITED LABORATORIES INC
Creditor Name: SHANGRI-LA
Endorsed Date:
Address: 66 UNITED STREET MANDALUYONG
CITY
Amount: 82,094.90
Currency: PESO (PHILIPPINES)
Closed Date: NA
Status: PENDING
Reason:
Remarks:
CARDS CANCELLED
RESULTS
1.
No Records Found for UNITED LAB
COURT CASES
RESULTS
1.
UNITED LABORATORIES INC
Case Number: 21188
Courts: METROPOLITAN TRIAL COURT
Address:
Branch: 59
Case Type: DAMAGES
Amount: 0
Plaintiff Name: KANAPI ROBERTO RICARDO O
Action: UNAVAILABLE
Date Filed:
Action Date: NA
City: MANDALUYONG CITY
Remarks:
2.
UNITED LABORATORIES INC
Case Number: MC05 2825
Courts: REGIONAL TRIAL COURT
Address:
Branch: 214
Case Type: SPECIFIC PERFORMANCE WITH
DAMAGES
Amount:
Plaintiff Name: CRUZ DANILO L
Action: UNAVAILABLE
Date Filed:
Action Date: NA
City: MANDALUYONG CITY
Remarks: RE RAFFLED TO BRANCH 212 ON
3.
UNITED LABORATORIES INC
Case Number: MC05 2830
Courts: REGIONAL TRIAL COURT
Address:
Branch: 211
Case Type: SUM OF MONEY
Amount:
Plaintiff Name: RGC CJEMICAL COMPANY INC
Action: UNAVAILABLE
Date Filed:
Action Date: NA
City: MANDALUYONG CITY
Remarks:
4.
UNITED LABORATORIES INC
Case Number: 09 899
Courts: REGIONAL TRIAL COURT
Address:
Branch: 66
Case Type: INFRINGEMENT OF PATENT
INJUNCTION
Amount: 0
Plaintiff Name: WARNER LAMBERT COMPANY
LLC
Action: UNAVAILABLE
Date Filed:
Action Date: NA
City: MAKATI CITY
Remarks:
No negative
records (court cases, credit cards cancelled and delinquent accounts) found
under the name “UNILAB” in available database as of August 31,
2012.
Above information
were based on the subject’s 2011 General Information Sheet, the latest
available at the Securities and Exchange Commission and available databases.
Address
verification per interview with Ms. Carla Cos, Front Desk Clerk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.45 |
|
|
1 |
Rs.87.98 |
|
Euro |
1 |
Rs.69.69 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.